Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on March 24, 2020.
September 24, 2020 at 03:56 am EDT
Share
From April 1, 2020 to September 24, 2020, the company has repurchased 51,620 shares, representing 1.02% for KRW 2,597.61 million. With this, the company has completed the repurchase of 60,620 shares, representing 1.2% for KRW 2,988.45 million under the buyback announced on March 24, 2020.
HLscience Co., Ltd. is a Korea-based company primarily engaged in development, manufacture and distribution of healthcare products. The company manufactures products in the areas of live health, climacteric women health, stomach health, antioxidant/skin health, immunity, blood circulation improvement, eye health, intestinal health, articulation health, fatigue/stamina, diet, antioxidant/immunity, multi-vitamin/mineral/calcium, male health and general foods. The Company distributes its productions within domestic market and to overseas markets.